Biltema Foundation donates 260 million to research on revolutionary method for cancer treatment

Biltema Foundation donates 260 million to research on revolutionary method for cancer treatment

FLASH radiotherapy is a new form of radiation treatment developed by researchers at the University Hospital in Lausanne. The method has proven to be very effective in the treatment of cancer, while also sparing the adjacent healthy tissues to a remarkable degree. Biltema Foundation has now donated 260 million to the project to further develop this revolutionary method for cancer treatment.

The method has been shown to be effective in treating skin cancer, and at the same time saves the nearby healthy tissue. The limitations are often due to the inaccessibility of the tumors, and in the event of treatment, the surrounding tissue would have been excessively damaged.
Researchers at Lausanne University Hospital have developed a new type of radiotherapy called FLASH. The intensity of the radiation enables the same radiotherapeutic effect on the tumor, but administrated for milliseconds instead of minutes. With this method, the radiation is directed at the tumor with much higher precision, and the surrounding tissue is affected to a considerably lesser extent.
The phenomenon that FLASH radiotherapy is based on was discovered in 2014, and already in 2018, the first patient was treated successfully with this method. With funding from, among others, the donation from Biltema Foundation, the goal is now to further develop this form of treatment and continue to cure cancer patients.

Read more about FLASH radiotherapy here.